Randle P J
Nuffield Department of Clinical Biochemistry, University of Oxford, Radcliffe Infirmary, U.K.
Diabetes Metab Rev. 1998 Dec;14(4):263-83. doi: 10.1002/(sici)1099-0895(199812)14:4<263::aid-dmr233>3.0.co;2-c.
Competition for respiration between substrates in animal tissues has been known for at least 80 years. The most important interaction, quantitatively is between glucose and fatty acids. The starting point in 1963 for the so called Glucose Fatty Acid Cycle was the realisation that the metabolic relationship between glucose and fatty acids is reciprocal and not dependent. Glucose provision promotes glucose oxidation and glucose and lipid storage, and inhibits fatty acid oxidation. Provision of free fatty acids promotes fatty acid oxidation and storage, inhibits glucose oxidation and may promote glucose storage if glycogen reserves are incomplete. This review is concerned predominantly with evidence in man in vivo. In the authors opinion the evidence for inhibitory effects of fatty acids on whole body glucose utilization ad oxidation (predominantly muscles) is decisive and enzyme mechanisms mediating these effects are well established. There is also much evidence that fatty acid oxidation inhibits glucose oxidation and stimulates glucose formation in liver and again enzyme mechanism are known. A permissive role for fatty acids in the insulin secretory response of islet beta-cells has now been firmly established and can be visualised as a mechanism to protect continuing provision of respiratory substrate. Longer term exposure of islet beta-cells to fatty acids impairs the insulin secretory response to glucose and mechanisms are known. There is compelling evidence that fatty acid oxidation may impair glucose oxidation in uncontrolled Type 1 and Type 2 diabetes, but no convincing evidence that fatty acids have a role in diminished glucose storage (glycogen deposition) in Type 2 diabetes. The inhibition of glucose storage which may follow prolonged elevation of plasma FFA in man and experimental animals is associated with glycogen repletion whereas the inhibition of glucose storage in Type 2 diabetes is associated with glycogen depletion. The precise role of fatty acids in disturbed carbohydrate metabolism in Type 2 diabetes is an area where future progress is confidently predicted.
动物组织中底物之间的呼吸竞争至少已为人所知80年了。从数量上看,最重要的相互作用发生在葡萄糖和脂肪酸之间。1963年所谓的葡萄糖脂肪酸循环的起点是人们认识到葡萄糖和脂肪酸之间的代谢关系是相互的且并非相互独立。提供葡萄糖会促进葡萄糖氧化以及葡萄糖和脂质的储存,并抑制脂肪酸氧化。提供游离脂肪酸会促进脂肪酸氧化和储存,抑制葡萄糖氧化,并且如果糖原储备不完整,可能会促进葡萄糖储存。本综述主要关注人体体内的证据。作者认为,脂肪酸对全身葡萄糖利用和氧化(主要是肌肉)的抑制作用的证据是决定性的,介导这些作用的酶机制也已明确。也有很多证据表明脂肪酸氧化会抑制葡萄糖氧化并刺激肝脏中的葡萄糖生成,而且酶机制也已为人所知。现在已经明确确立了脂肪酸在胰岛β细胞胰岛素分泌反应中的允许作用,并且可以将其视为一种保护呼吸底物持续供应的机制。胰岛β细胞长期暴露于脂肪酸会损害其对葡萄糖的胰岛素分泌反应,其机制也已为人所知。有令人信服的证据表明脂肪酸氧化可能会损害1型和2型未控制糖尿病中的葡萄糖氧化,但没有令人信服的证据表明脂肪酸在2型糖尿病中葡萄糖储存减少(糖原沉积)方面起作用。在人和实验动物中,血浆游离脂肪酸长期升高后可能出现的葡萄糖储存抑制与糖原补充有关,而2型糖尿病中的葡萄糖储存抑制与糖原耗竭有关。脂肪酸在2型糖尿病碳水化合物代谢紊乱中的确切作用是一个有望在未来取得进展的领域。